ACT 064992
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACT 064992, covering 2022-02-10 to 2022-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension [Phase 3]